跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Vincer Michael J.
Assistant Professor
Dalhousie University
,
Atelier Future
电子邮件
VM560497
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=6603560497
h-index
h10-index
h5-index
3759
引用
29
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
1054
引用
13
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
107
引用
7
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1987 …
2023
每年的科研成果
综述
指纹
网络
科研成果
(72)
新闻 / 媒体
(1)
相似简介
(6)
指纹
深入其中 Vincer Michael J. 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Neonatal Intensive Care Unit
100%
Prematurity
78%
Pregnancy
76%
Gestational Age
71%
Cohort Analysis
54%
Childbirth
53%
Spastic Diplegia
51%
Bayley Scales of Infant Development
45%
Randomized Controlled Trial
44%
Antenatal Corticosteroid
40%
Lung Dysplasia
40%
Retinopathy of Prematurity
35%
Premature Labor
27%
Health Care Cost
26%
Neonatal Infant
25%
Birth Weight
20%
Hearing Impairment
19%
Pediatrics
17%
Brain Injury
16%
Monochorionic Twins
16%
Encephalomalacia
16%
Neonate
16%
Sepsis
16%
Hypothermia
15%
Prevalence
15%
Corticosteroid Therapy
15%
Developmental Delay
14%
Echography
13%
Obstetrics
13%
Blood Transfusion
13%
Umbilical Cord
13%
Substance Use
13%
Circumcision
13%
Sensitivity and Specificity
13%
Perinatal Morbidity
13%
Systematic Review
13%
Meta-Analysis
13%
Newborn Intensive Care
13%
Prognostic Factor
13%
Synostosis
13%
Hypoxic-Ischemic Encephalopathy
13%
Intrapartum
13%
Hypoxemia
13%
Dysostosis
13%
Hyperbilirubinemia
13%
Extremely Low Birth Weight
13%
Diastolic Function
13%
Hypoxic Ischemic Encephalopathy
13%
Cystic Hygroma
13%
Dexamethasone
13%
Keyphrases
Gestational Age
32%
Canada
29%
Retinopathy of Prematurity
28%
Nova Scotia
28%
Respiratory Distress Syndrome
27%
Very Preterm Infants
27%
Population-based Study
27%
Survivors
17%
Disability
15%
Cerebral Palsy
15%
Loss Prevention
13%
Adaptive Test
13%
Outcome-based
13%
Bayley Scales of Infant Development-II
13%
Randomized Controlled Trial
13%
Antenatal Corticosteroids
13%
Assurance Activities
13%
Corticosteroid Prophylaxis
13%
Preterm Gestation
13%
Late Preterm
13%
Mother's Milk
13%
Beclomethasone
13%
Circumcision
13%
Maternal Side
13%
Early childhood Outcomes
13%
Multiple Courses
13%
Confidence Interval
13%
Placebo
13%
Intermittent Hypoxemia
13%
Birth Weight
13%
Hypoxemia
13%
Extremely Preterm Infants
13%
Bradycardia
13%
Late Death
13%
Smoking Outcomes
13%
Nipissing
13%
Bone-conducted
13%
Indomethacin Prophylaxis
13%
Polyethylene Wrap
13%
Baseline Temperature
13%
Dysostosis
13%
Risk Prognosis
13%
Prognostic Factors
13%
Hypoxic-ischemic Encephalopathy
13%
FZD4
13%
Intrapartum Risk Factors
13%
Synthetic Air
13%
Adjusted Age
13%
Synthetic Surfactant
13%
Male-female Differences
13%
Nursing and Health Professions
Gestational Age
49%
Neonatal Intensive Care Unit
34%
Neonate
27%
Lung Dysplasia
27%
Respiratory Distress Syndrome
19%
Birth Weight
16%
Mortality Rate
16%
Cohort Analysis
15%
Premature Labor
15%
Sepsis
13%
Intention to Treat Analysis
13%
High Risk Population
13%
Literature Review
13%
Quality Control
13%
Brain Injury
13%
Corticosteroid Therapy
13%
Indometacin
13%
Patent Ductus Arteriosus
13%
Health Care Quality
13%
Rate Ratio
13%
Prevalence
13%
Practice Guideline
13%
Retrolental Fibroplasia
13%
Twin Twin Transfusion Syndrome
13%
Beclometasone
13%
Cerebral Palsy
13%
Live Birth
9%
Health Care Personnel
9%
Stress Assessment
9%
Intravenous Drug Administration
6%
Perinatal Mortality
6%
Digestive System Perforation
6%
Auditory Screening
6%
Drug Therapy
6%
Medication Error
6%
Twin Pregnancy
6%
Hypertrophic Cardiomyopathy
5%
Child Death
5%
Intermittent Positive Pressure Breathing
5%
Confidence Interval
5%
Labor Induction
5%
